X-L Xu

MiR-99a suppresses cell migration and invasion by regulating IGF1R in gastric cancer.

Qingyun Pan, A. Guo, X-L Xu, 2019, European review for medical and pharmacological sciences.

Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.

D.P. Zhao, X-L Xu, Y. Gong, 2018, European review for medical and pharmacological sciences.

The potential mechanism of INHBC and CSF1R in diabetic nephropathy.

W. Zhang, M. Liu, B. Zheng, 2020, European review for medical and pharmacological sciences.

Interaction between bone marrow-derived dendritic cells and miR-21 of tubular renal epithelial cells under hypoxia.

T. Zhang, P. Jia, Y. Fang, 2019, European review for medical and pharmacological sciences.

Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.

W. Ling, L-Y Sun, R. Tao, 2020, European review for medical and pharmacological sciences.

Urinary apolipoprotein M could be used as a biomarker of acute renal injury: an ischemia-reperfusion injury model of kidney in rat.

N. Xu, X-Z He, X-L Xu, 2013, Transplantation proceedings.